Mulmit

Emergent BioSolutions Inc.Emergent BioSolutions Inc.

EBS NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31742,900,000100,100,00052,600,0000.93
2024-12-311,043,600,000-108,700,000-190,600,000-3.6
2023-12-311,049,300,000-726,400,000-760,500,000-14.85
2020-12-311,555,400,000438,500,000305,800,0005.68
2019-12-311,106,000,000114,100,00054,500,0001.04

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-01Williams Paul AnthonySVP, Products Business3,000
2026-06-08Hartzel WilliamSVP, Bioservices1,741
2026-06-08Williams Paul AnthonySVP, Products Business694
2026-06-08Glessner ColeenEVP, Quality & Ethics, and CPL2,018
2026-06-08LINDAHL RICHARD SEVP, Chief Financial Officer3,964
2026-05-01Zoon Kathryn C16,145
2026-05-01Zoon Kathryn C1,057
2026-05-01DeGolyer Donald W14,527
2026-05-01DeGolyer Donald W954
2026-05-01Dayal Sujata Tyagi12,781
2026-05-01Dayal Sujata Tyagi980
2026-04-30Zoon Kathryn C25,344

8-K events

FiledItems
2026-09-01Other events · Financial statements and exhibits
2026-08-05Results of operations · Costs associated with exit or disposal activities · Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-06-29Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-04-30Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-04-30Submission of matters to a vote · Financial statements and exhibits
2026-04-17Entry into a material agreement · Termination of a material agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
2026-03-03Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-02-26Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.

한국 시장 대시보드Korea dashboard 미국·글로벌 대시보드US & Global dashboard